who should not take glp 1 medications Chart: in 8 Americans Now Use GLP-1 Drugs for Weight Loss If you've ever found yourself

Nutrition and behavior change remain foundational, whether someone chooses to use a GLP-1 or not. In the first nine months of 2025, major pharmaceutical companies spent more than $700 million advertising GLP-1 medications2, with Eli Lilly spending approximately $34 million on television spots in January 2026.3 Yet the 2026 Virta Vitals report suggests that growing awareness of GLP-1s has not necessarily translated into greater willingness to use them

Li AQ, Zhao L, Zhou TF, Zhang MQ, Qin XM

If youve previously had a heart attack and youre experiencing chest pain again, that warrants an immediate call for an ambulance, he adds

GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management

Semaglutide: A Strong Contender Wegovy, known generically as Semaglutide, has become widely recognized for its substantial efficacy in promoting weight loss